Clinical Trials on Stage IIIB Non-Small Cell Lung Cancer AJCC v7 in Germany
Total 595 results
-
GlaxoSmithKlineTerminatedNeoplasmsUnited States, Germany, Netherlands, Canada, Australia, Sweden
-
Helsinn Therapeutics (U.S.), IncCompletedNon-Small Cell Lung Cancer | CachexiaUnited States, Poland, Ukraine, Belgium, Germany, Spain, Belarus, Slovenia, Serbia, Netherlands, Canada, Russian Federation, Hungary, Czechia, France, Italy
-
Novartis PharmaceuticalsTerminatedMelanoma | Ovarian Neoplasms | Non-Small-Cell Lung Carcinoma | Other Solid TumorsSpain, Germany, Singapore, Switzerland, Japan, United States
-
Ariad PharmaceuticalsTakedaActive, not recruitingALK-positive Advanced NSCLCKorea, Republic of, United States, Spain, Taiwan, Canada, Hong Kong, China, Sweden, Australia, Italy, Japan, Germany, Netherlands, France, Austria
-
Helsinn Therapeutics (U.S.), IncCompletedNon-Small Cell Lung Cancer | CachexiaPoland, Ukraine, United States, Belgium, Spain, Belarus, Slovenia, Serbia, Canada, Russian Federation, Australia, Hungary, Germany, Czechia, France, Israel, Italy
-
GlaxoSmithKlineCompletedLung Cancer, Small CellSpain, France, Netherlands, Korea, Republic of, Greece, Slovenia, Italy, Czech Republic, Germany, Austria, Hungary, Poland, Estonia, Lithuania
-
TakedaActive, not recruitingALK+ Advanced NSCLCSpain, China, Korea, Republic of, Taiwan, Hong Kong, Thailand, Italy, Romania, United States, Mexico, Croatia, Russian Federation, Argentina, Canada, Germany, France, Austria, Chile, Greece, Sweden
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingNon-Small Cell Lung CancerKorea, Republic of, United States, Japan, Spain, Italy, Belgium, France, Germany
-
University Hospital TuebingenAstraZenecaRecruitingCarcinoma, Non-Small-Cell Lung | Pathology, MolecularGermany
-
Novartis PharmaceuticalsTerminatedColorectal Cancer | Gastrointestinal Stromal Tumors | Non-small Cell Lung Carcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal SCCUnited States, Germany, Spain, Singapore, Australia, Hong Kong, Belgium, Japan, China
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-squamous Non-small-cell LungPoland, Korea, Republic of, Ukraine, United States, Argentina, Australia, Austria, Canada, France, Japan, New Zealand, Romania, Russian Federation, Taiwan, Turkey, United Kingdom, Brazil, Colombia, Germany, Spain
-
iOMEDICO AGBristol-Myers SquibbCompletedNab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC (NEPTUN)Carcinoma, Non-Small-Cell LungGermany
-
Boehringer IngelheimActive, not recruitingCarcinoma, Non-Small-Cell LungGermany
-
TransgeneCompletedCarcinoma, Non-Small-Cell LungFrance, Germany, Hungary, Poland
-
Novartis PharmaceuticalsTerminatedMelanoma | Non-Small Cell Lung CancerItaly, Australia, Belgium, Germany, Spain, Korea, Republic of, Israel, France, United States, Sweden, Poland
-
Boehringer IngelheimRecruitingNeoplasm Metastasis | Non-Small Cell Lung CancerUnited States, Hong Kong, Spain, Korea, Republic of, China, Israel, Germany, Japan, Singapore, Australia, United Kingdom, Austria, Netherlands, France, Portugal, Sweden, Italy, Belgium
-
Hoffmann-La RocheJazz PharmaceuticalsActive, not recruitingSmall-Cell Lung CancerUnited States, Belgium, Italy, Spain, Turkey, United Kingdom, Korea, Republic of, Germany, Mexico, Hungary, Taiwan, Greece, Poland
-
Janssen Research & Development, LLCRecruitingCarcinoma, Non-small-Cell LungUnited States, Korea, Republic of, Italy, Israel, Malaysia, United Kingdom, China, Brazil, Spain, Germany, Japan, France
-
Mologen AGCompletedSmall Cell Lung CancerBelgium, Spain, Austria, Germany
-
AmMax Bio, Inc.Merck Sharp & Dohme LLCCompletedColorectal Cancer | Pancreatic Cancer | Non-Small Cell Lung CancerCanada, United States, Australia, Belgium, Spain, Germany
-
AmgenActive, not recruitingRelapsed/Refractory Small Cell Lung CancerUnited States, Belgium, Italy, Spain, Portugal, Austria, Greece, Korea, Republic of, Denmark, Netherlands, Germany, France, Taiwan, Japan, United Kingdom, Poland, Switzerland, Singapore
-
Eli Lilly and CompanyActive, not recruitingNon Small Cell Lung CancerItaly, United States, Spain, Germany, Korea, Republic of, Poland, Romania, Taiwan, Ukraine, France, Japan, Russian Federation, Austria, Israel, Greece, Brazil, Argentina, Turkey, Canada, Puerto Rico, China
-
Genentech, Inc.RecruitingColorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid TumorsUnited States, Korea, Republic of, Spain, United Kingdom, Brazil, Israel, New Zealand, Netherlands, Canada, Australia, Switzerland, Belgium, Italy, Norway, Poland, Hungary, Kenya, Russian Federation, Germany
-
Universität Duisburg-EssenEli Lilly and CompanyUnknown
-
Eli Lilly and CompanyCompletedLung Neoplasms | Mesothelioma | Non-small Cell Lung CancerSpain, Germany, Denmark
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) MutationsUnited States, Japan, Spain, France, Australia, Italy, Korea, Republic of, United Kingdom, Canada, Germany, Turkey, Hong Kong
-
EMD SeronoTerminatedCarcinoma, Non-Small-Cell LungUnited States, Germany
-
Aktion Bronchialkarzinom e.V.Boehringer IngelheimCompleted
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; National Taiwan University Hospital; Duke... and other collaboratorsTerminatedSmall Cell Lung CancerUnited States, Taiwan, Germany, Belgium, United Kingdom
-
AmgenRecruitingSmall Cell Lung Cancer (SCLC)China, United States, Australia, Netherlands, Taiwan, Spain, Canada, Korea, Republic of, Turkey, Israel, Austria, Japan, France, United Kingdom, Germany, Belgium, Denmark, Czechia, Switzerland, Italy, Hungary, Ireland, Argentina, Brazil, Malays... and more
-
University Medical Center GroningenCentre Hospitalier Universitaire de Nice; LungenClinic GrosshansdorfRecruitingLung Cancer Stage IIIFrance, Germany, Netherlands
-
PharmaMarCompletedSmall-cell Lung CancerFrance, United States, Germany, Spain, Belgium, Lebanon, United Kingdom, Italy, Netherlands, Brazil, Portugal, Greece, Argentina, Austria, Bulgaria, Canada, Czechia, Hungary, Poland, Romania
-
German Breast GroupRoche Pharma AG; Celgene CorporationCompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
SanofiRegeneron PharmaceuticalsCompletedCarcinoma | Non Small Cell LungUnited States, France, Canada, Brazil, Poland, Romania, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Bulgaria, Estonia, India, Malaysia, Singapore, Taiwan, Czech Republic, Argentina, Finland, Hungary, Korea... and more
-
NovoCure GmbHActive, not recruitingNSCLC | Nonsmall Cell Lung CancerUnited States, Poland, Hong Kong, China, Spain, Serbia, Croatia, France, Canada, Netherlands, Austria, Belgium, Bulgaria, Czechia, Germany, Hungary, Italy, Switzerland
-
PharmaMarRecruitingRelapsed Small Cell Lung CancerUnited States, Spain, Japan, Korea, Republic of, United Kingdom, Israel, France, Taiwan, Germany, Australia, Belgium, Georgia, Italy, Switzerland, Denmark, Hungary, Poland, Romania, Canada, Brazil, Bulgaria, Austria, Chile, Turkey
-
EMD SeronoTerminatedCarcinoma, Non-Small-Cell LungUnited States, Germany
-
Merck KGaA, Darmstadt, GermanyTerminatedMultiple Myeloma | Non-Small Cell Lung CancerGermany
-
Michael HoppBoehringer IngelheimActive, not recruiting
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungGermany
-
Merck Sharp & Dohme LLCCompletedSmall Cell Lung Cancer (SCLC)United States, Australia, Canada, Chile, France, Germany, Hungary, Ireland, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Switzerland, Taiwan, Turkey, United Kingdom
-
German Breast GroupCelgene Corporation; AmgenCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
CNAO National Center of Oncological HadrontherapyFondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Fondazione IRCCS... and other collaboratorsRecruitingMelanoma | Non Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial CarcinomaItaly, Germany
-
CelgeneActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Italy, France, Germany, Greece, Spain
-
Cantargia ABActive, not recruitingColorectal Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreatic Ductal AdenocarcinomaAustria, Denmark, Germany, Belgium, Spain, Latvia, Netherlands, Lithuania, Estonia, Sweden, Norway
-
Prof. Dr. Juergen WolfCharite University, Berlin, Germany; University Hospital, Essen; Goethe University and other collaboratorsRecruitingCarcinoma, Non-Small-Cell LungGermany
-
CelgeneCompletedCarcinoma, Non-Small-Cell LungUnited States, Canada, France, Germany, Italy, Spain, United Kingdom
-
ETOP IBCSG Partners FoundationCompleted
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor PharmaCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
Novartis PharmaceuticalsCompletedStudy of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung CancerCarcinoma, Non-Small-Cell LungUnited States, Belgium, Germany, France, Spain, Israel